REDOX signaling from reactive oxygen species (ROS) generated by the mitochondria (mitochondrial reactive oxygen species [mtROS]) has been implicated in cancer growth and survival. Here, we investigated the effect of 5-(4-methoxyphenyl)-3H-1,2-dithiole-3-thione (AOL), a recently characterized member of the new class of mtROS suppressors (S1QELs), on human lung adenocarcinoma proteome reprogramming, bioenergetics, and growth.
Results:
AOL reduced steady-state cellular ROS levels in human lung cancer cells without altering the catalytic activity of complex I. AOL treatment induced dose-dependent inhibition of lung cancer cell proliferation and triggered a reduction in tumor growth in vivo. Molecular investigations demonstrated that AOL reprogrammed the proteome of human lung cancer cells. In particular, AOL suppressed the determinants of the Warburg effect and increased the expression of the complex I subunit NDUFV1 which was also identified as AOL binding site using molecular modeling computer simulations. Comparison of the molecular changes induced by AOL and MitoTEMPO, an mtROS scavenger that is not an S1QEL, identified a core component of 217 proteins commonly altered by the two treatments, as well as drug-specific targets.
Innovation:
This study provides proof-of-concept data on the anticancer effect of AOL on mouse orthotopic human lung tumors. A unique dataset on proteomic reprogramming by AOL and MitoTEMPO is also provided. Lastly, our study revealed the repression of NDUFV1 by S1QEL AOL.
Conclusion:
Our findings demonstrate the preclinical anticancer properties of S1QEL AOL and delineate its mode of action on REDOX and cancer signaling.
Get full access to this article
View all access options for this article.
References
1.
AminEM, LiuY, DengS, TanKS, ChudgarN, MayoMW, Sanchez-VegaF, AdusumilliPS, SchultzN, and JonesDR. The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK. Sci Signal, 10: eaah3941, 2017.
2.
AmoedoND, ObreE, and RossignolR. Drug discovery strategies in the field of tumor energy metabolism: limitations by metabolic flexibility and metabolic resistance to chemotherapy. Biochim Biophys Acta Bioenerg, 1858: 674–685, 2017.
3.
AranyZ, HeH, LinJ, HoyerK, HandschinC, TokaO, AhmadF, MatsuiT, ChinS, WuP-H, RybkinII, SheltonJM, ManieriM, CintiS, SchoenFJ, Bassel-DubyR, RosenzweigA, IngwallJS, and SpiegelmanBM. Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle. Cell Metab, 1: 259–271, 2005.
BalasubramanianMN, ButterworthEA, and KilbergMS. Asparagine synthetase: regulation by cell stress and involvement in tumor biology. Am J Physiol Endocrinol Metab, 304: E789–E799, 2013.
6.
BerndtsonWE. A simple, rapid and reliable method for selecting or assessing the number of replicates for animal experiments. J Anim Sci, 69: 67–76, 1991.
7.
BrandMD, GoncalvesRLS, OrrAL, VargasL, GerencserAA, Borch JensenM, WangYT, MelovS, TurkCN, MatzenJT, DardovVJ, PetrassiHM, MeeusenSL, PerevoshchikovaIV, JasperH, BrookesPS, and AinscowEK. Suppressors of superoxide-H2O2 production at site I Q of mitochondrial complex I protect against stem cell hyperplasia and ischemia-reperfusion injury. Cell Metab, 24: 582–592, 2016.
8.
CaoS, LiuY, WangH, MaoX, ChenJ, LiuJ, XiaZ, ZhangL, LiuX, and YuT. Ischemic postconditioning influences electron transport chain protein turnover in Langendorff-perfused rat hearts. Peer J, 4: e1706, 2016.
9.
CartoniR, LegerB, HockMB, PrazM, CrettenandA, PichS, ZiltenerJL, LuthiF, DeriazO, ZorzanoA, GobeletC, KralliA, and RussellAP. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol, 567: 349–358, 2005.
10.
ChatfieldKC, SparagnaGC, ChauS, PhillipsEK, AmbardekarAV, AftabM, MitchellMB, SucharovCC, MiyamotoSD, and StaufferBL. Elamipretide improves mitochondrial function in the failing human heart. JACC Basic Transl Sci, 4: 147–157, 2019.
11.
ChenX, LvY, SunY, ZhangH, XieW, ZhongL, ChenQ, LiM, LiL, FengJ, YaoA, ZhangQ, HuangX, YuZ, and YaoP. PGC1β regulates breast tumor growth and metastasis by SREBP1-mediated HKDC1 expression. Front Oncol, 9: 290, 2019.
12.
ChengG, ZielonkaJ, McAllisterD, HardyM, OuariO, JosephJ, DwinellMB, and KalyanaramanB. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: role of mitochondrial bioenergetics and energy-sensing mechanism. Cancer Lett, 365: 96–106, 2015.
13.
ChengG, ZielonkaJ, McAllisterDM, MackinnonAC, JosephJ, DwinellMB, and KalyanaramanB. Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death. BMC Cancer, 13: 285, 2013.
14.
ChouchaniET, MethnerC, NadtochiySM, LoganA, PellVR, DingS, JamesAM, CocheméHM, ReinholdJ, LilleyKS, PartridgeL, FearnleyIM, RobinsonAJ, HartleyRC, SmithRAJ, KriegT, BrookesPS, and MurphyMP. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med, 19: 753–759, 2013.
15.
Corazao-RozasP, GuerreschiP, JendoubiM, AndréF, JonneauxA, ScalbertC, GarçonG, Malet-MartinoM, BalayssacS, RocchiS, SavinaA, FormstecherP, MortierL, KluzaJ, and MarchettiP. Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor. Oncotarget, 4: 1986–1998, 2013.
16.
DetailleD, PasdoisP, SémontA, Dos SantosP, and DiolezP. An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals. PLoS One, 14: e0216385, 2019.
17.
This reference has been deleted.
18.
EirinA, EbrahimiB, ZhangX, ZhuX-Y, WoollardJR, HeQ, TextorSC, LermanA, and LermanLO. Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease. Cardiovasc Res, 103: 461–472, 2014.
19.
EstevesP, DardL, BrillacA, HubertC, SarlakS, RousseauB, DumonE, IzotteJ, BonneuM, LacombeD, DupuyJ-W, AmoedoN, and RossignolR. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene, 39: 617–636, 2020.
20.
FiedorczukK, LettsJA, DegliespostiG, KaszubaK, SkehelM, and SazanovLA. Atomic structure of the entire mammalian mitochondrial complex I. Nature, 538: 406–410, 2016.
21.
GentricG, KiefferY, MieuletV, GoundiamO, BonneauC, NematiF, HurbainI, RaposoG, PopovaT, SternM-H, Lallemand-BreitenbachV, MüllerS, CañequeT, RodriguezR, Vincent-SalomonA, de ThéH, RossignolR, and Mechta-GrigoriouF. PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers. Cell Metab, 29: 156–173.e10, 2019.
22.
GranjaS, PinheiroC, ReisRM, MartinhoO, and BaltazarF. Glucose addiction in cancer therapy: advances and drawbacks. Curr Drug Metab, 16: 221–242, 2015.
23.
GrossmanRL, HeathAP, FerrettiV, VarmusHE, LowyDR, KibbeWA, and StaudtLM. Toward a shared vision for cancer genomic data. N Engl J Med, 375: 1109–1112, 2016.
24.
This reference has been deleted.
25.
HoWY, YeapSK, HoCL, RahimRA, and AlitheenNB. Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay. PLoS One, 7: e44640, 2012.
HosseiniM, RezvaniH, ArouaN, BoscC, FargeT, SalandE, Guyonnet-DupératV, ZaghdoudiS, JarrouL, LarrueC, SabatierM, MouchelPL, GotanègreM, PiechaczykM, BossisG, RécherC, and SarryJ-E. Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia. Cancer Res, 79: 5191–5203, 2019.
28.
IdelchikMDPS, BegleyU, BegleyTJ, and MelendezJA. Mitochondrial ROS control of cancer. Semin Cancer Biol, 47: 57–66, 2017.
29.
JacqueminG, MargiottaD, KasaharaA, BassoyEY, WalchM, ThieryJ, LiebermanJ, and MartinvaletD. Granzyme B-induced mitochondrial ROS are required for apoptosis. Cell Death Differ, 22: 862–874, 2015.
30.
JanssenMCH, KoeneS, de LaatP, HemelaarP, PickkersP, SpaansE, BeukemaR, BeyrathJ, GroothuisJ, VerhaakC, and SmeitinkJ. The KHENERGY study: safety and efficacy of KH176 in mitochondrial m.3243A>G spectrum disorders. Clin Pharmacol Ther, 105: 101–111, 2019.
31.
KällL, CanterburyJD, WestonJ, NobleWS, and MacCossMJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods, 4: 923–925, 2007.
32.
KluzaJ, Corazao-RozasP, TouilY, JendoubiM, MaireC, GuerreschiP, JonneauxA, BallotC, BalayssacS, ValableS, Corroyer-DulmontA, BernaudinM, Malet-MartinoM, de LassalleEM, MaboudouP, FormstecherP, PolakowskaR, MortierL, and MarchettiP. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res, 72: 5035–5047, 2012.
33.
KukidomeD, NishikawaT, SonodaK, ImotoK, FujisawaK, YanoM, MotoshimaH, TaguchiT, MatsumuraT, and ArakiE. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes, 55: 120–127, 2006.
34.
KuriyamaS, YoshidaM, YanoS, AibaN, KohnoT, MinamiyaY, GotoA, and TanakaM. LPP inhibits collective cell migration during lung cancer dissemination. Oncogene, 35: 952–964, 2016.
35.
LeeH, KimB-W, LeeJ-W, HongJ, LeeJ-W, KimH-L, LeeJ-S, and KoY-G. Extracellular reactive oxygen species are generated by a plasma membrane oxidative phosphorylation system. Free Radic Biol Med, 112: 504–514, 2017.
36.
LeiC, DengJ, WangB, ChengD, YangQ, DongH, and XiongL. Reactive oxygen species scavenger inhibits STAT3 activation after transient focal cerebral ischemia–reperfusion injury in rats. Anesth Analg, 113: 153–159, 2011.
37.
LiuT, ChenL, KimE, TranD, PhinneyBS, and KnowltonAA. Mitochondrial proteome remodeling in ischemic heart failure. Life Sci, 101: 27–36, 2014.
38.
This reference has been deleted.
39.
LudvikAE, PusecCM, PriyadarshiniM, AngueiraAR, GuoC, LoA, HershenhouseKS, YangG-Y, DingX, ReddyTE, LoweWL, LaydenBT, and LaydenBT. HKDC1 is a novel hexokinase involved in whole-body glucose use. Endocrinology, 157: 3452–3461, 2016.
MurphyMP. How mitochondria produce reactive oxygen species. Biochem J, 417: 1–13, 2009.
43.
NakajimaT, TanakaN, LiG, HuR, KamijoY, HaraA, and AoyamaT. Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice. Redox Rep, 15: 123–130, 2010.
44.
NazarewiczRR, DikalovaA, BikineyevaA, IvanovS, KirilyukIA, Grigor'evIA, and DikalovSI. Does scavenging of mitochondrial superoxide attenuate cancer prosurvival signaling pathways?. Antioxid Redox Signal, 19: 344–349, 2013.
45.
PayenVL, PorporatoPE, DanhierP, VazeilleT, BlackmanMCNM, MayBH, NiebesP, and SonveauxP. (+)-Catechin in a 1:2 complex with lysine inhibits cancer cell migration and metastatic take in mice. Front Pharmacol, 8: 869, 2017.
46.
PierriCL, ParisiG, and PorcelliV. Computational approaches for protein function prediction: a combined strategy from multiple sequence alignment to molecular docking-based virtual screening. Biochim Biophys Acta, 1804: 1695–1712, 2010.
47.
PorporatoPE, PayenVL, Pérez-EscuredoJ, De SaedeleerCJ, DanhierP, CopettiT, DhupS, TardyM, VazeilleT, BouzinC, FeronO, MichielsC, GallezB, and SonveauxP. A mitochondrial switch promotes tumor metastasis. Cell Rep, 8: 754–766, 2014.
RezvaniHR, DedieuS, NorthS, BellocF, RossignolR, LetellierT, de VerneuilH, TaiebA, and MazurierF. Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J Biol Chem, 282: 16413–16422, 2007.
50.
RezvaniHR, KimAL, RossignolR, AliN, DalyM, MahfoufW, BellanceN, TaiebA, de VerneuilH, MazurierF, and BickersDR. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest, 121: 195–211, 2011.
51.
This reference has been deleted.
52.
This reference has been deleted.
53.
RossmanMJ, Santos-ParkerJR, StewardCAC, BisphamNZ, CuevasLM, RosenbergHL, WoodwardKA, ChoncholM, Gioscia-RyanRA, MurphyMP, and SealsDR. Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension, 71: 1056–1063, 2018.
54.
SantidrianAF, Matsuno-YagiA, RitlandM, SeoBB, LeBoeufSE, GayLJ, YagiT, and Felding-HabermannB. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest, 123: 1068–1081, 2013.
55.
SiauciunaiteR, FoulkesNS, CalabròV, and ValloneD. Evolution shapes the gene expression response to oxidative stress. Int J Mol Sci, 20: 3040, 2019.
56.
SrivastavaA, SrivastavaKR, HebbarM, GaladaC, KadavigrereR, SuF, CaoX, ChinnaiyanAM, GirishaKM, ShuklaA, and BielasSL. Genetic diversity of NDUFV1-dependent mitochondrial complex I deficiency. Eur J Hum Genet, 26: 1582–1587, 2018.
57.
TsaiM-L, HuangH-P, HsuJ-D, LaiY-R, HsiaoY-P, LuF-J, and ChangH-R. Topical N-acetylcysteine accelerates wound healing in vitro and in vivo via the PKC/Stat3 pathway. Int J Mol Sci, 15: 7563–7578, 2014.
58.
UngvariZ, LabinskyyN, MukhopadhyayP, PintoJT, BagiZ, BallabhP, ZhangC, PacherP, and CsiszarA. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Circ Physiol, 297: H1876–H1881, 2009.
59.
VargheseF, AtchesonE, BridgesHR, and HirstJ. Characterization of clinically identified mutations in NDUFV1, the flavin-binding subunit of respiratory complex I, using a yeast model system. Hum Mol Genet, 24: 6350–6360, 2015.
60.
VernisL, El BannaN, BaïlleD, HatemE, HenemanA, and HuangM-E. Fe-S clusters emerging as targets of therapeutic drugs. Oxid Med Cell Longev, 2017: 3647657, 2017.
61.
This reference has been deleted.
62.
VichaiV and KirtikaraK. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc, 1: 1112–1116, 2006.
63.
WangG, LiuX, XieJ, MengJ, and NiX. PDK-1 mediated Hippo–YAP–IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells. Biosci Rep, 39: BSR20182099, 2019.
64.
WeinbergF, HamanakaR, WheatonWW, WeinbergS, JosephJ, LopezM, KalyanaramanB, MutluGM, BudingerGR, and ChandelNS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A, 107: 8788–8793, 2010.
65.
WillemsPHGM, RossignolR, DieterenCEJ, MurphyMP, and KoopmanWJH. Redox homeostasis and mitochondrial dynamics. Cell Metab, 22: 207–218, 2015.
66.
WilsonRJ, DrakeJC, CuiD, LewellenBM, FisherCC, ZhangM, KashatusDF, PalmerLA, MurphyMP, and YanZ. Mitochondrial protein S- nitrosation protects against ischemia reperfusion-induced denervation at neuromuscular junction in skeletal muscle. Free Radic Biol Med, 117: 180–190, 2018.
67.
WongH-S, BenoitB, and BrandMD. Mitochondrial and cytosolic sources of hydrogen peroxide in resting C2C12 myoblasts. Free Radic Biol Med, 130: 140–150, 2019.
68.
WongH-S, DighePA, MezeraV, MonternierP-A, and BrandMD. Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions. J Biol Chem, 292: 16804–16809, 2017.
69.
XuZ, JinX, CaiW, ZhouM, ShaoP, YangZ, FuR, CaoJ, LiuY, YuF, FanR, ZhangY, ZouS, ZhouX, YangN, ChenX, and LiY. Proteomics analysis reveals abnormal electron transport and excessive oxidative stress cause mitochondrial dysfunction in placental tissues of early-onset preeclampsia. Proteomics Clin Appl, 12: 1700165, 2018.
70.
YizhakK, Le DévédecSE, RogkotiVM, BaenkeF, de BoerVC, FrezzaC, SchulzeA, van de WaterB, and RuppinE. A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol Syst Biol, 10: 744, 2014.
71.
ZhangB, TaoF, and ZhangH. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways. Mol Med Rep, 17: 4899–4908, 2018.
72.
ZorovDB, JuhaszovaM, and SollottSJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev, 94: 909–950, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
